Wilson Sonsini Goodrich & Rosati has advised 4E Therapeutics. 4E Therapeutics, an Austin-based neuroscience company, has announced its acquisition by Eli Lilly and Company (NYSE: LLY)....
Eli Lilly Acquires 4E Therapeutics to Expand Chronic Pain Treatment Portfolio
Redaptive’s $650 Million Credit Facility
Wilson Sonsini Goodrich & Rosati advised Redaptive on the transaction. Redaptive, a leading Energy-as-a-Service (EaaS) provider, announced the successful closing of a $650 million (CAD 903...
Tenstorrent’s $693 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati advised Tenstorrent on the transaction. Tenstorrent, a next-generation computing company that builds computers for AI, announced the closing of over $693...